Company Filing History:
Years Active: 1999-2000
Title: The Innovations of Bill R. Reisdorph
Introduction
Bill R. Reisdorph is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that address various medical conditions. With a total of 2 patents to his name, his work has the potential to impact many lives.
Latest Patents
One of his latest patents involves Butenolide endothelin antagonists. These novel nonpeptides are characterized by having a carbamic group and serve as antagonists of endothelin I. The patent describes methods for their preparation and pharmaceutical compositions containing these compounds. The applications of these compounds are extensive, as they are useful in treating elevated levels of endothelin, which can lead to conditions such as hypertension, myocardial infarction, diabetes, and more. The compounds also show promise in treating cerebral vasospasm, cirrhosis, septic shock, congestive heart failure, and various other serious health issues.
Career Highlights
Bill R. Reisdorph has been associated with Warner-Lambert Company, where he has contributed to groundbreaking research and development in the pharmaceutical industry. His work has not only advanced scientific knowledge but has also paved the way for new treatment options for patients suffering from various ailments.
Collaborations
Throughout his career, Bill has collaborated with esteemed colleagues, including William Chester Patt and Joseph Thomas Repine. These collaborations have fostered an environment of innovation and have led to the successful development of new therapeutic agents.
Conclusion
Bill R. Reisdorph's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to improving healthcare. His work continues to inspire future advancements in medical treatments.